Back to Report Store Home

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • Published: Mar-2018
  • Report Code: GBIHC470MR
  • Report Format: pdf

Description

List of Tables

Table 1: ACR-EULAR Classification Criteria for Rheumatoid Arthritis, 2010 13

Table 2: RA Therapeutics Market, Global, Licensing Deals Valued over $10m, 2006–2017 101

Table 3: RA Therapeutics Market, Global, Co-development Deals Valued over $10m, 2006–2017 110

Table 4: RA Therapeutics Market, Global, All Pipeline Products, Discovery, 2016 112

Table 5: RA Therapeutics Market, Global, All Pipeline Products, Preclinical, 2016 115

Table 6: RA Therapeutics Market, Global, All Pipeline Products, Investigational New Drug, 2016 125

Table 7: RA Therapeutics Market, Global, All Pipeline Products, Phase I, 2016 125

Table 8: RA Therapeutics Market, Global, All Pipeline Products, Phase II, 2016 128

Table 9: RA Therapeutics Market, Global, All Pipeline Products, Phase III, 2016 130

Table 10: RA Therapeutics Market, Global, All Pipeline Products, Pre-registration, 2016 131

Table 11: RA Therapeutics Market, APAC, Market Forecast, 2016–2023 131

Table 12: RA Therapeutics Market, India, Market Forecast, 2016–2023 132

Table 13: RA Therapeutics Market, China, Market Forecast, 2016–2023 132

Table 14: RA Therapeutics Market, Australia, Market Forecast, 2016–2023 132

Table 15: RA Therapeutics Market, South Korea, Market Forecast, 2016–2023 133

Table 16: RA Therapeutics Market, Japan, Market Forecast, 2016–2023 133

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards